In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Elaine Hylek
Speaker
Elaine Hylek
Elaine Hylek Elaine Hylek

Boston University, Boston (United States of America)

Speciality : Atrial Fibrillation

13 presentations from this speaker

10 years since RE-LY: applying innovations in anticoagulation

Event : ESC Congress 2019

  • Session : 10 years since RE-LY: applying innovations in anticoagulation
  • Speaker : E Hylek (Boston,US), H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

NOACs: key features on safety, continuity, and reversibility.

Event : ESC Congress 2018

  • Session : Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
  • Speaker : E Hylek (Boston,US)
  • Sponsored by Boehringer Ingelheim

Panel discussion and Q&A - Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice.

Event : ESC Congress 2018

  • Session : Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
  • Speaker : E Hylek (Boston,US), H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

State of the Art lecture 2 - The link between hemostasis and cancer: what is clinically relevant?

Event : ESC Congress 2018

  • Session : Antithrombotics and cancer: challenges in clinical practice
  • Speaker : E Hylek (Boston,US)

Introduction - Advancing patient care with NOACs: focus on VTE management.

Event : ESC Congress 2017

  • Session : Advancing patient care with NOACs: focus on VTE management
  • Speaker : E Hylek (Boston,US)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Oral anticoagulation and thrombosis: multidisciplinary perspectives on patient management.

Event : ESC Congress 2017

  • Session : Oral anticoagulation and thrombosis: multidisciplinary perspectives on patient management
  • Speaker : A Cohen (London,GB), E Hylek (Boston,US), G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Future direction for research in antithrombotic therapy in atrial fibrillation.

Event : ESC Congress 2016

  • Session : Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation?
  • Speaker : E Hylek (Boston,US)

Patient with a low risk of embolic stroke - Clinical case

Event : ESC Congress 2016

  • Session : Challenges of antithrombotic prophylaxis in atrial fibrillation
  • Speaker : E Hylek (Boston,US)

Panel discussion and Q&A - Your patients, your practice, your choice: Novel Oral AntiCoagulants (NOACs) in the clinic.

Event : ESC Congress 2015

  • Session : Your patients, your practice, your choice: NOACs in the clinic
  • Speaker : E Hylek (Boston,US)
  • Sponsored by Boehringer Ingelheim

Anticoagulant use in patients with atrial fibrillation: daily management challenges.

Event : ESC Congress 2014

  • Session : Rivaroxaban in cardiology: current practice and exploring future directions
  • Speaker : E Hylek (Boston,US)
  • Sponsored by Bayer HealthCare

State of the Art lecture: "New insights into prevention of thromboambolic events in atrial fibrillation".

Event : ESC Congress 2014

  • Session : State of the Art - New insights into prevention of thromboembolic events in atrial fibrillation
  • Speaker : E Hylek (Boston,US)

Intracranial haemorrhage during treatment with a novel oral anticoagulant.

Event : ESC Congress 2013

  • Session : Challenges in the management of atrial fibrillation
  • Speaker : E Hylek (Boston,US)

Panel discussion.

Event : ESC Congress 2013

  • Session : Challenges in the management of atrial fibrillation
  • Speaker : R Hobbs (Oxford,GB), E Hylek (Boston,US), P Kirchhof (Edgbaston,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are